RELX is not a strong buy right now for a beginner long-term investor with fresh capital who is unwilling to wait for a better entry. The stock looks technically soft in pre-market, sentiment from options is mixed-to-bearish, and the latest analyst moves show valuation concerns outweighing near-term upside. While the business remains fundamentally resilient and hedge funds are buying, the current setup does not offer an attractive immediate entry. I would not call it a clear buy today; hold off for a better price.
Current pre-market price is 32.37, down 2.18%, which is weaker than the broader market's +0.16% pre-market move. The chart is bearish: MACD histogram is negative and still contracting, RSI_6 is neutral at 45.92, and moving averages are stacked bearishly with SMA_200 > SMA_20 > SMA_5. Price is also trading below the pivot at 32.887, with immediate support at 31.84 and resistance at 33.933. The short-term trend is weak, and the stock trend model suggests a 70% chance of a small decline over the next day and week, though it may recover over the next month.

["Hedge funds are buying, with buying up 147.40% over the last quarter.", "Citi upgraded RELX to Buy on 2026-04-08, saying AI concerns are overdone.", "BofA kept a Buy rating on 2026-03-09 and noted Q4 earnings showed resilience with little/no discernible impact from AI concerns.", "No major negative news in the last week, so there is no fresh event-driven deterioration.", "The business appears resilient based on recent analyst commentary."]
["Morgan Stanley downgraded RELX to Equal Weight on 2026-05-07 and cut its target, citing valuation and more balanced risk/reward.", "The stock is down 2.18% in pre-market and is underperforming the broader market.", "Technical indicators are bearish, including negative MACD and bearish moving-average structure.", "Open interest put-call ratio of 1.45 points to defensive positioning.", "No news catalysts in the recent week to support an immediate move higher."]
No financial snapshot was provided because the latest-quarter data returned an error, so a quarter-by-quarter financial review is not available here. Based on the analyst notes, the most recent referenced quarter was Q4, and it was described as resilient with no clear adverse impact from AI concerns. That suggests stable growth characteristics rather than a sharp deterioration, but the missing financials prevent a deeper assessment of latest-quarter revenue, margins, or EPS growth.
Analyst sentiment is mixed but has become more cautious recently. Citi upgraded the stock to Buy in April, but Morgan Stanley downgraded it to Equal Weight in May and lowered its target on valuation grounds. BofA remains constructive with a Buy rating and a higher target, emphasizing resilience and limited AI impact. Overall, Wall Street appears split: bulls like the durability of the business and the AI narrative, while bears are increasingly focused on valuation and limited upside at current levels.